BSE filing, NSE: SVGLOBAL. Summary written from the filing by ALFA Finder's alert engine.
SV Global Mill Ltd: key numbers
- Share price
- ₹128.10
- Market cap
- ₹231.6 Cr
- Revenue (annual)
- ₹3.45 Cr
- Net profit (annual)
- ₹-9.03 Cr
- P/E (TTM)
- -81.2×Sector 34.0×
- Promoter holding
- 68.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SV Global Mill Ltd
All →SV Global Mill Management Change
SV Global Mill appointed Mr. K. Vijayasarathi as Chief Financial Officer, effective 26 October 2026. He brings over 20 years of finance, accounts and audit experience.
SV Global Mill Q2 FY27 Results: Turns Profitable, Net Profit ₹1.5 Cr
SV Global Mill Ltd reported revenue from operations of ₹0.6 Cr (-25.0% YoY) and net profit of ₹1.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹1.5 Cr
SV Global Mill Board Meeting Date
S V Global Mill Ltd will hold a board meeting on October 24, 2026, to consider and approve standalone and consolidated un-audited financial results.
SV Global Mill Merger & Restructuring
S V Global Mill Limited's board approved a Scheme of Arrangement for the cancellation of 10,91,187 unclaimed physical shares. This capital reduction will shift all shares to demat mode.
SV Global Mill Board Meeting Date
S V Global Mill Limited scheduled a board meeting for August 28, 2026. The board will consider a scheme of arrangement to cancel physical shares held in a suspense account.
SV Global Mill Q1 FY27 Results: Net Profit ₹4.8 Cr, Up 500.0% YoY
SV Global Mill Ltd reported revenue from operations of ₹0.7 Cr (-53.3% YoY) and net profit of ₹4.8 Cr (+500.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹4.8 Cr · +500.0% YoY
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.